Prevalence of Hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria
INTRODUCTION: Hepatitis B infection impacts negatively on disease progression in HIV infected children thereby increasing morbidity and mortality. In spite of the foregoing, data on Hepatitis B co-infection in children living with HIV in South Eastern Nigeria is scarce. This study set out to determine the prevalence of Hepatitis B Co- infection in HIV infected children attending the Paediatric HIV Care and Treatment clinic of the Federal Medical Centre Owerri. METHODS: Study period was between February and July 2010. Testing for Hepatitis B infection was done using the ACON Hepatitis B surface antigen Rapid test strip. (Acon Laboratories Inc. San Diego.CA) on HIV infected children attending the Paediatric HIV Care and Treatment clinic of the Federal Medical Centre Owerri. RESULTS: A total of 139 HIV infected children were enrolled during the study period. The overall prevalence of Hepatitis B Co- infection was 5.8% (8/139). The prevalence in males was 8.2% (5/61) while in females it was 3.8% (3/78). The prevalence of Hepatitis B Co- infection amongst patients on antiretroviral therapy was 4.6%. They accounted for 62.5% of Hepatitis B Co- infection in our study. Previous blood transfusion, gender and age did not show significant relationship with Hepatitis B Co-infection. CONCLUSION: The high prevalence of Hepatitis B Co- infection in our study poses an intense treatment challenge because suggested drug combinations in patients with HIV and Hepatitis B infections are not commonly available in resource challenged centres like ours. It would appear then that our best option would be to prevent Hepatitis B infection in both HIV infected and un-infected children. This can be achieved by strengthening the uptake of Hepatitis B vaccine which is already incorporated in the National Programme on Immunization (NPI) in Nigeria..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
The Pan African Medical Journal - 14(2013), 89 Zur Gesamtaufnahme - volume:14 |
---|
Sprache: |
Englisch ; Französisch |
---|
Beteiligte Personen: |
Emeka Nwolisa [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Children |
---|
doi: |
10.11604/pamj.2013.14.89.1711 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ07460371X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ07460371X | ||
003 | DE-627 | ||
005 | 20230309125238.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.11604/pamj.2013.14.89.1711 |2 doi | |
035 | |a (DE-627)DOAJ07460371X | ||
035 | |a (DE-599)DOAJ4518480d619e465f8d411f6351f98cad | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a fre | ||
100 | 0 | |a Emeka Nwolisa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of Hepatitis B co-infection amongst HIV infected children attending a care and treatment centre in Owerri, South-eastern Nigeria |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a INTRODUCTION: Hepatitis B infection impacts negatively on disease progression in HIV infected children thereby increasing morbidity and mortality. In spite of the foregoing, data on Hepatitis B co-infection in children living with HIV in South Eastern Nigeria is scarce. This study set out to determine the prevalence of Hepatitis B Co- infection in HIV infected children attending the Paediatric HIV Care and Treatment clinic of the Federal Medical Centre Owerri. METHODS: Study period was between February and July 2010. Testing for Hepatitis B infection was done using the ACON Hepatitis B surface antigen Rapid test strip. (Acon Laboratories Inc. San Diego.CA) on HIV infected children attending the Paediatric HIV Care and Treatment clinic of the Federal Medical Centre Owerri. RESULTS: A total of 139 HIV infected children were enrolled during the study period. The overall prevalence of Hepatitis B Co- infection was 5.8% (8/139). The prevalence in males was 8.2% (5/61) while in females it was 3.8% (3/78). The prevalence of Hepatitis B Co- infection amongst patients on antiretroviral therapy was 4.6%. They accounted for 62.5% of Hepatitis B Co- infection in our study. Previous blood transfusion, gender and age did not show significant relationship with Hepatitis B Co-infection. CONCLUSION: The high prevalence of Hepatitis B Co- infection in our study poses an intense treatment challenge because suggested drug combinations in patients with HIV and Hepatitis B infections are not commonly available in resource challenged centres like ours. It would appear then that our best option would be to prevent Hepatitis B infection in both HIV infected and un-infected children. This can be achieved by strengthening the uptake of Hepatitis B vaccine which is already incorporated in the National Programme on Immunization (NPI) in Nigeria. | ||
650 | 4 | |a hepatitis b infection | |
650 | 4 | |a hiv infection | |
650 | 4 | |a children | |
650 | 4 | |a immunization | |
650 | 4 | |a prevalence | |
650 | 4 | |a disease progression | |
650 | 4 | |a hiv care and treatment | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Francis Mbanefo |e verfasserin |4 aut | |
700 | 0 | |a Joseph Ezeogu |e verfasserin |4 aut | |
700 | 0 | |a Paul Amadi |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t The Pan African Medical Journal |g 14(2013), 89 |
773 | 1 | 8 | |g volume:14 |g year:2013 |g number:89 |
856 | 4 | 0 | |u https://doi.org/10.11604/pamj.2013.14.89.1711 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/4518480d619e465f8d411f6351f98cad |z kostenfrei |
856 | 4 | 0 | |u https://www.panafrican-med-journal.com/content/article/14/89/pdf/89.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1937-8688 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 14 |j 2013 |e 89 |